BRR OpCo’s Provectus Biopharmaceuticals PVCT Stock Holding History
Bought
Maintained
Sold
Other funds holding PVCT
BRR OpCo's PVCT Position: Q1 2019 in Review
BRR OpCo sold out of Provectus Biopharmaceuticals (PVCT) in Q1 2019, closing a stake of 40,000 shares — an estimated $2K sold.
BRR OpCo first reported a position in PVCT in Q4 2017 and held it in 5 quarters. The position peaked at $3K in Q3 2018. 4 funds tracked by Wall St. Rank hold PVCT as of Q1 2019.
- BRR OpCo reported no remaining Provectus Biopharmaceuticals position as of Q1 2019 after selling out during the quarter.
- BRR OpCo sold 40,000 Provectus Biopharmaceuticals shares in Q1 2019, an estimated $2K.
- BRR OpCo first reported a position in Provectus Biopharmaceuticals in Q4 2017 and held it in 5 quarters.
- BRR OpCo's Provectus Biopharmaceuticals position peaked at $3K in Q3 2018.
- 4 funds tracked by Wall St. Rank held Provectus Biopharmaceuticals as of Q1 2019.
Based on BRR OpCo's 13F filing for Q1 2019, filed 26 Apr 2019.